|
ANKLE2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.312899999943E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.46060000000226E-05 |
| Normal-vs-Stage2 |
1.130230E-01 |
| Normal-vs-Stage3 |
5.489800E-02 |
| Normal-vs-Stage4 |
1.224590E-01 |
| Stage1-vs-Stage2 |
8.156600E-01 |
| Stage1-vs-Stage3 |
9.085000E-01 |
| Stage1-vs-Stage4 |
8.134400E-01 |
| Stage2-vs-Stage3 |
9.215400E-01 |
| Stage2-vs-Stage4 |
7.460200E-01 |
| Stage3-vs-Stage4 |
8.016000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.25580000001724E-06 |
| Normal-vs-AfricanAmerican |
8.574500E-04 |
| Normal-vs-Asian |
2.407000E-01 |
| Caucasian-vs-AfricanAmerican |
8.289200E-01 |
| Caucasian-vs-Asian |
5.149200E-01 |
| AfricanAmerican-vs-Asian |
4.808400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.8484999999856E-06 |
| Normal-vs-Female |
1.429800E-04 |
| Male-vs-Female |
6.930400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.381750E-02 |
| Normal-vs-Extreme_Weight |
3.816800E-03 |
| Normal-vs-Obese |
6.45439999999997E-05 |
| Normal-vs-Extreme_Obese |
4.229000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.841200E-01 |
| Normal_Weight-vs-Obese |
2.980400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.683000E-01 |
| Extreme_Weight-vs-Obese |
1.685000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.153200E-01 |
| Obese-vs-Extreme_Obese |
1.845220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.410490E-04 |
| Normal-vs-Age(41-60Yrs) |
2.29090000003485E-06 |
| Normal-vs-Age(61-80Yrs) |
5.846500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.334000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.160410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.045900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.679000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.312600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.348800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.164800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.82129999865199E-08 |
| Normal-VS-Type2 PRCC |
5.685000E-01 |
| Normal-VS-KIRP CIMP |
3.354400E-02 |
| Normal-VS-Unclassified PRCC |
2.021200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.248600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.626600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.518800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.076300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.184400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.170800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.460800E-01 |
| Normal-vs-N1 |
1.044020E-02 |
| Normal-vs-N2 |
3.157900E-03 |
| N0-vs-N1 |
4.888300E-02 |
| N0-vs-N2 |
1.404580E-01 |
| N1-vs-N2 |
9.443200E-01 |
|
|
